Pharma and Biotech
| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | n/a |
| ROCE | 393.8% |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | n/a | n/a |
| Pr/Book | n/a |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | n/a | (0.99) | (0.59)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | n/a | (1.34) | (0.46)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | n/a | (1.86) | (0.64)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | n/a | (1.59) | (0.47)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Issue of Equity & PDMR Notifications | 05-Mar-2026 | 10:55 | RNS |
| Result of GM | 02-Mar-2026 | 12:30 | RNS |
| Receipt of First Tranche of Grant | 02-Mar-2026 | 07:00 | RNS |
No recent information was found.
| Traded | Action | Notifier | Price | Amount | Value |
|---|---|---|---|---|---|
| 02-Mar-26 | Placing | Gad Berdugo | 190.00p | 965,789 | £1,834,999.08 |
| 02-Mar-26 | Placing | Eric Leire | 190.00p | 965,789 | £1,834,999.08 |
| Currency | UK Pounds |
| Share Price | 1.98p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 2.25 |
| 52 Week Low | 0.62 |
| Volume | 21,381 |
| Shares Issued | 535.65m |
| Market Cap | £10.58m |
| Beta | 0.00 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 14:02 | 1,500 @ 1.85p |
| 13:49 | 3,800 @ 1.88p |
| 12:13 | 11,000 @ 1.88p |
| 08:00 | 5,081 @ 1.88p |
You are here: research